Dacomatinib is now available in India for EGFR Positive Lung Cancer. This drug is better than first generation gefitinib and second generation afatinib in many senses.
(22-June-2020)
Dacomatinib is now available in India for EGFR Positive Lung Cancer. This drug is better than first generation gefitinib and second generation afatinib in many senses.